OAM
APYX icon

Oxford Asset Management’s Apyx Medical APYX Stock Holding History

Oxford Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-130,965
Closed -$849K – 1646
2018
Q4 		$849K Buy
+130,965
New +$793K 0.02% 941

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Oxford Asset Management's APYX Position: Q1 2019 in Review

Oxford Asset Management sold out of Apyx Medical (APYX) in Q1 2019, closing a stake of 130,965 shares — an estimated $849K sold.

Oxford Asset Management first reported a position in APYX in Q4 2018 and held it in 1 quarter. The position peaked at $849K in Q4 2018. 78 funds tracked by Wall St. Rank hold APYX as of Q1 2019.

  • Oxford Asset Management reported no remaining Apyx Medical position as of Q1 2019 after selling out during the quarter.
  • Oxford Asset Management sold 130,965 Apyx Medical shares in Q1 2019, an estimated $849K.
  • Oxford Asset Management first reported a position in Apyx Medical in Q4 2018 and held it in 1 quarter.
  • Oxford Asset Management's Apyx Medical position peaked at $849K in Q4 2018.
  • 78 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.